Richard D. Press - Concepedia

Author

Richard D. Press

Oregon Health & Science University ORCID

Also Known As

Kamel-Reid, Suzanne, Press, Richard, R D Press, R PRESS, R Press, R. D. PRESS, R. D. Press, R. Press, RD Press, Richard D Press

180

Publications

4.9K

Citations

H-Index

Concepts

All Affiliations

Oregon Health & Science University Howard Hughes Medical Institute University of Utah University of Minnesota The University of Texas MD Anderson Cancer Center

About

Richard D. Press is an author at Oregon Health & Science University specializing in medicine, hematology, and molecular diagnostics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	29	1.6K
2	Health Sciences	4	4	172
3	Public Health	3	3	153
4	Engineering	2	2	76
5	Natural Sciences	2	2	56

Richard D. Press

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials Susan Branford, Linda Fletcher, Nicholas C.P. Cross, Blood	2008	386
BCR-ABL1 Compound Mutations Combining Key Kinase Domain Positions Confer Clinical Resistance to Ponatinib in Ph Chromosome-Positive Leukemia Matthew S. Zabriskie, Christopher A. Eide, Srinivas K. Tantravahi, Cancer Cell Hematological MalignancyPh Chromosome-positive LeukemiaGeneticsMolecular GeneticsCancer Genetics	2014	363
TNFα facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms Angela G. Fleischman, Karl J. Aichberger, Samuel B. Luty, Blood	2011	280
Common Mutation in Methylenetetrahydrofolate Reductase Thomas G. DeLoughery, A. Evans, Abbas Sadeghi, Circulation	1996	235
Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA Helen White, Paul Matejtschuk, Peter Rigsby, Blood	2010	156
BCR-ABL mRNA levels at and after the time of a complete cytogenetic response (CCR) predict the duration of CCR in imatinib mesylate–treated patients with CML Richard D. Press, Zac Love, Ashlie Tronnes, Blood	2006	125
A Half-Log Increase in BCR-ABL RNA Predicts a Higher Risk of Relapse in Patients with Chronic Myeloid Leukemia with an Imatinib-Induced Complete Cytogenetic Response Richard D. Press, Chad Galderisi, Rui Yang, Clinical Cancer Research	2007	122
Clinical utility of factor V leiden (R506Q) testing for the diagnosis and management of thromboembolic disorders. Richard D. Press, Kenneth A. Bauer, Jody L. Kujovich, PubMed	2002	112
Biological Variability of Transferrin Saturation and Unsaturated Iron-Binding Capacity Paul C. Adams, David M. Reboussin, Richard D. Press, The American Journal of Medicine Transferrin SaturationNutrient BioavailabilityBiochemistryBioanalysisMetabolism	2007	112
The genomic basis of childhood T-lineage acute lymphoblastic leukaemia Petri Pölönen, Danika Di Giacomo, Anna Eames Seffernick, Nature Hematological MalignancyGenomic BasisMixed-phenotype Acute LeukemiaGeneticsHematology	2024	111

Page 1